UBS Group Lowers Envista (NYSE:NVST) Price Target to $27.00

Envista (NYSE:NVST) had its price target reduced by analysts at UBS Group from $30.00 to $27.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside of 16.61% from the stock’s current price.

Other equities analysts have also issued reports about the company. Barclays lowered their price target on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, June 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a report on Friday. Mizuho set a $29.00 target price on Envista in a report on Thursday, August 6th. BMO Capital Markets reaffirmed a “market perform” rating on shares of Envista in a research note on Thursday, September 10th. Finally, Wall Street Zen lowered Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.86.

Envista Stock Down 2.3%

NVST stock opened at $23.15 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The firm has a market capitalization of $3.72 billion, a P/E ratio of 40.02, a P/E/G ratio of 1.19 and a beta of 0.86. Envista has a 52-week low of $18.77 and a 52-week high of $30.42. The company’s 50 day simple moving average is $27.01 and its 200-day simple moving average is $26.06.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. Envista’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities research analysts anticipate that Envista will post 1.53 EPS for the current year.

Insider Buying and Selling

In related news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the sale, the senior vice president owned 27,321 shares in the company, valued at approximately $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Tidal Investments LLC boosted its position in shares of Envista by 2.4% during the second quarter. Tidal Investments LLC now owns 23,555 shares of the company’s stock worth $621,000 after buying an additional 547 shares during the period. WINTON GROUP Ltd grew its stake in shares of Envista by 247.9% during the 2nd quarter. WINTON GROUP Ltd now owns 192,055 shares of the company’s stock worth $5,061,000 after acquiring an additional 136,855 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of Envista in the second quarter valued at approximately $210,000. Squarepoint Ops LLC bought a new stake in shares of Envista in the second quarter worth $1,464,000. Finally, Allworth Financial LP boosted its holdings in Envista by 56.1% during the second quarter. Allworth Financial LP now owns 3,441 shares of the company’s stock worth $91,000 after purchasing an additional 1,237 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral-care professionals.

Envista’s portfolio includes dental imaging and diagnostic systems, digital dentistry and CAD/CAM solutions, dental implants, orthodontic brackets and wires, clear aligner products, endodontic instruments, restorative materials, infection-prevention products and other dental consumables.